153 results on '"Dubois, Stefan V."'
Search Results
2. Current Pathologic Scoring Systems for Metal-on-metal THA Revisions are not Reproducible
3. Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT
4. Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?
5. Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study
6. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
7. False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma
8. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric–metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma
9. Pagetʼs disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET
10. Bone marrow 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma
11. Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma
12. Lymphoma grading with FDG-PET/CT readdressed : Direct and timely histopathological correlation study
13. Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT
14. Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT
15. Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT
16. Variety in bone marrow F-18-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement : does it have an explanation?
17. Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma
18. Where Does Diffuse Large B-Cell Lymphoma Relapse?
19. Where Does Diffuse Large B-Cell Lymphoma Relapse?
20. Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study
21. Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT
22. Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma
23. Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma
24. Variety in bone marrow F-18-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
25. Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT
26. Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma
27. Where Does Diffuse Large B-Cell Lymphoma Relapse?
28. Bone marrow biopsy in diffuse large B-cell lymphoma : Useful or redundant test?
29. Residual anatomical disease in diffuse large B-cell lymphoma patients with FDG-PET-based complete response after first-line R-CHOP therapy : Does it have any prognostic value?
30. Prognostic value of anemia and C-reactive protein levels in diffuse large B-cell lymphoma
31. Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?
32. False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma
33. Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma
34. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma
35. Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET
36. Residual anatomical disease in diffuse large B-cell lymphoma patients with FDG-PET-based complete response after first-line R-CHOP therapy: Does it have any prognostic value?
37. Prognostic value of anemia and C-reactive protein levels in diffuse large B-cell lymphoma
38. Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?
39. Bone marrow biopsy in diffuse large B-cell lymphoma: Useful or redundant test?
40. Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma
41. Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET
42. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma
43. False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma
44. Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma
45. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
46. Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects
47. Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study
48. Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma
49. Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance
50. Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET–Based Complete Response After First-Line R-CHOP Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.